Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Well
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Analytics
Lauran Neergaard
Stay informed with Lauran Neergaard’s coverage and analysis for Fortune.
Page 4 of 5
Health
FDA clears Pfizer boosters for 12-to-15 year-olds
By
Lauran Neergaard
and
The Associated Press
Health
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By
Lauran Neergaard
,
Mike Stobbe
, and others
Health
FDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
CDC advisory panel recommends COVID vaccine for kids 5 to 11
By
Lauran Neergaard
,
Mike Stobbe
, and others
Health
FDA authorizes COVID vaccine for kids ages 5 to 11
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
FDA panel backs Pfizer’s COVID vaccine for kids ages 5 to 11
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
The CDC will allow people to choose what booster shot they get—no matter what COVID vaccine they got before
By
Lauran Neergaard
,
Mike Stobbe
, and others
Health
FDA approves Moderna and Johnson & Johnson boosters, as well as mixing COVID vaccines
By
Matthew Perrone
,
Lauran Neergaard
, and others
Health
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
FDA debates timeline for administering Johnson & Johnson booster shots
By
Matthew Perrone
,
Lauran Neergaard
, and others
Health
FDA panel will advise on Johnson & Johnson booster shots this week
By
Lauran Neergaard
,
Matthew Perrone
, and others
Health
Biden urges eligible Americans to get COVID booster shots ASAP
By
Lauran Neergaard
,
Mike Stobbe
, and others
Health
CDC director overrules panel to offer COVID booster shots to health care workers
By
Lauran Neergaard
,
Mike Stobbe
, and others
Health
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
By
Matthew Perrone
,
Lauran Neergaard
, and others
Health
Days after the FDA rejected COVID booster shots for people 16 and up, a CDC panel will decide who gets an extra dose
By
Lauran Neergaard
,
Mike Stobbe
, and others